- Investing Ideas
- Chinese Pharmaceuticals & Biotech Healthy high growth potential
Chinese Pharmaceuticals & Biotech Healthy high growth potential
Results
7
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
7 companies
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥23.8b
A commercial-stage biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of oncology and hematologic disorders.
688192
CN¥51.05
7D
-8.2%
1Y
-33.2%
Xiamen Amoytop Biotech
Market Cap: CN¥23.6b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥58.35
7D
-0.9%
1Y
-35.7%
PharmaResources (Shanghai)
Market Cap: CN¥4.0b
Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.
301230
CN¥24.44
7D
-1.1%
1Y
-16.2%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥8.1b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥22.22
7D
-4.8%
1Y
-34.5%
AcrobiosystemsLtd
Market Cap: CN¥7.9b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥48.38
7D
-7.4%
1Y
-11.7%
Inner Mongolia Furui Medical Science
Market Cap: CN¥11.5b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥45.38
7D
7.5%
1Y
3.8%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥6.5b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥12.42
7D
3.2%
1Y
-21.8%